跳至主要内容
临床试验/NCT01828268
NCT01828268Unknown不适用

Metabolic Fingerprintings and Metabolic Dynamics After HIV Infection:Impact of Metabolic Changes and Anti-Retroviral Therapy, Life Style and Clinical Conditions

Sichuan Academy of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Dyslipidemia

研究概览

简要总结

The purpose of this plot study is to find out the relationship between metabolic changes and anti-retroviral therapy (ART), life style and clinical conditions of HIV-infected patients using nuclear magnetic resonance (NMR) based systems biology approach and metabolomics methodology.

详细描述

Since the clinical application of anti-retroviral therapy (ART) in 1997, the life expectancy of HIV infected patients has been prolonged greatly. However,side effects of ART including metabolic abnormalities have become the main factors influencing patients' quality of life. Among which the abnormal lipid metabolism plays an important role. Meanwhile, metabolic conditions differ from patients applying to different combinations of ART drugs,life style and clinical conditions.

Metabolomics can measure the dynamic metabolic responses of the body to stimuli or modifications. Using nuclear magnetic resonance (NMR) as tools can systematically analyse the process of lipid metabolism. Metabolomics fingerprinting can be defined as the complete complement of small molecule (< 1500 Da) metabolites found in a specific cell, body fluid, organ or organism.

Therefore, the study of the impact of metabolic changes and anti-retroviral therapy (ART), life style and clinical conditions is of importance in enhancing the adherence and improving the clinical outcomes of HIV infected patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of HIV infection

排除标准

  • Pregnancy
  • Individual who is participating in other trial(s)

结局指标

主要结局

Dyslipidemia

时间窗: Dyslipidemia events from admission to discharge(Up to 6 months) )

次要结局

  • Lipoatrophy(Lipoarophy events from admission to discharge (up to 6 months))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验